Posted on by lowes1

KALBITOR(R) (ecallantide) Data Presented at American Academy of Allergy … – MarketWatch (press release)

KALBITOR(R) (ecallantide) Data Presented at American Academy of Allergy …
MarketWatch (press release)
(NASDAQ:DYAX) today announced the presentation of data from KALBITOR(R) (ecallantide) clinical studies in hereditary angioedema (HAE) at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting in Orlando, Florida.

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.